RT Book, Section
A1 Therapy, Hematology-Oncology
A2 Boyiadzis, Michael M.
SR Print(0)
ID 1190342338
T1 Lymphoma, Non-Hodgkin: CD30-Positive T-Cell Lymphoma Regimen: Brentuximab Vedotin
T2 Hematology-Oncology Therapy Updates
YR 2016
FD 2016
PB McGraw-Hill Education
PP New York, NY
SN 
LK hemonc.mhmedical.com/updatesContent.aspx?gbosid=479157
RD 2022/06/29
AB